Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative disorders like Parkinson's disease, and other serious illnesses. Now, a new ...

In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.

The therapy is a nonmultiplying gene therapy vector, or transporter, which is a modified form of the herpes virus. This vector carries the gene encoding the active part of botulinum toxin, which ...

Botox (botulinum toxin) works by temporarily paralyzing specific muscles, reducing wrinkles or addressing muscle overactivity ...

The 52-week, Phase Ib/IIa clinical trial will enroll people from 18 to 75 years of age who are at least 12 months post-spinal cord injury. The trial includes a five-year safety follow-up period ...